Slingshot Insights | Bpmc Overview

BPMC Overview

Upcoming Projects (BPMC)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (BPMC)

Don’t see a project related to the company you care about? Create your own!

Expired Projects (BPMC)

A 3rd Look - Understanding Disease Management in Systemic Mastocytosis - A Look at Pipeline Products from Blueprint & Deciphera
Tickers: BPMC, DCPH
Execute By: Sep 20, 2018

Upcoming & Overdue Catalysts (BPMC)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (BPMC)

Blueprint Medicines' (BPMC) to Present Avapritinib in Advanced Systemic mastocytosis (SM) Phase 2 Data at AACR April 11, 2021 from 2pm ET
Ticker: BPMC
Occurred on: Apr 11, 2021
Blueprint Medicines'(BPMC) Pralsetinib Treatment of RET-Mutant Medullary Thyroid Cancer and RET Fusion-Positive Thyroid Cancer PDUFA Date due February 28, 2021
Ticker: BPMC
Occurred on: Dec 01, 2020
Phase 2 updated data of Blueprint Medicines' (BPMC) Avapritinib BLU-285 - PIONEER trial in Indolent and smoldering systemic mastocytosis (SM) due at the AAAAI Annual Meeting March 14, 2020
Ticker: BPMC
Occurred on: Mar 16, 2020

Strategic Initiatives (BPMC)

Blueprint Medicines (BPMC) to acquire Lengo Therapeutics for $250M in cash
Ticker: BPMC
Announcement Date: Nov 29, 2021